Participation in the Congress is open to clinicians and researchers throughout the world interested in the exchange of information on drug therapy in HIV infection. Only fully paid, pre-registered delegates will be allowed to take part in the congress.  The 2024 Congress will be running as a hybrid event giving attendees the choice of attending in-person in Glasgow or via our virtual platform.
Registration for the 2024 event is now open. Individuals can register using the link below. Accommodation options for individuals are available here.

For groups of 8 or more please email for a login to the group registration form. Please also use this address for group accommodation enquiries.

Mid In-person Registration Fee: £675
Mid Virtual Registration Fee: £350
Late In-person Registration Fee: £775
Late Virtual Registration Fee: £400

All fees include UK VAT @ 20%

In-person registration fees include access to all Congress sessions, Congress portal including live and on-demand content, exhibition hall, welcome reception, catering during coffee and lunch breaks from Sunday to Wednesday inclusive.
Virtual registration fees include access to the Congress portal including live and on-demand content. 

Cancellations Policy: Cancellations are permitted prior to 9 August 2024. Please email if you need to cancel your registration. The cancellation will be subject to an administrative fee of £125 which will be deducted from any refund due to you. After this date cancellations are not permitted.

Name changes: If you find yourself unable to attend the Congress, and a colleague is able to attend in your place, please notify the Organising Secretariat at indicating your full name and institution and the details of your colleague including full name, address and email contact details.  A name change fee of £125.00 will be payable.

Press registration: If you are interested in a press registration form, please click here.

Mid Fee From Saturday 1 June 2024
until Friday 30 August 2024
Late Fee From Saturday 31 August 2024
until Monday 28 October 2024